Journey Medical (DERM) Shares Outstanding (Diluted Average) (2021 - 2026)

Journey Medical has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $27.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 20.76% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $27.3 million (up 20.76% YoY), and the FY2025 full-year result was $24.5 million, up 19.9% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $27.3 million, up from $24.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $27.3 million in Q1 2026, with the low at $17.3 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $20.3 million across 5 years, with a median of $19.8 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) surged 92.33% — and 2023, when it gained 2.61%.
• Journey Medical's Shares Outstanding (Diluted Average) stood at $17.5 million in 2022, then increased by 4.0% to $18.2 million in 2023, then grew by 12.06% to $20.4 million in 2024, then gained by 19.9% to $24.5 million in 2025, then advanced by 11.46% to $27.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $27.3 million (Q1 2026), $24.5 million (Q4 2025), and $25.0 million (Q3 2025), per Business Quant data.